Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer

Federica Miglietta, Maria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, Grazia Vernaci, Alice Menichetti, Giovanni Faggioni, Tommaso Giarratano, Eleonora Mioranza, Elisa Genovesi, Enrico Cumerlato, Michele Bottosso, Tania Saibene, Silvia Michieletto, Marcello Lo Mele, Pierfranco Conte, Valentina Guarneri

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences